Why Repros Therapeutics Inc (RPRX) Was One Of Black Friday's Biggest Gainers
Shares of Repros Therapeutics Inc (NASDAQ:RPRX) ended up by 45.14% during today's truncated Black Friday trading session, following the Thanksgiving holiday.
Royalty Pharma Plc (RPRX)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
11 Insider Trades To Keep An Eye On
Insider buying activity has been shown to generate annual outperformance of about 7 percentage points, according to multiple empirical studies.
Repros Therapeutics: New Drug Development Stimulates Insider Trading
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at $23.77.
Safeway Inc. (SWY), DaVita HealthCare Partners Inc (DVA), Repros Therapeutics Inc (RPRX): Today's Three Best Stocks
It was, yet again, another positive day for the broad-based S&P 500 (INDEXSP:.INX), which has now pushed higher in 10 of the past 11 days and, once again, sits just a fraction off of its all-time high...
Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.
Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks. Two of the most underrated are hedge fund and insider trading movement.
Should You Buy XOMA Corp (XOMA)?
In the eyes of most stock holders, hedge funds are seen as unimportant, old investment vehicles of yesteryear.
Repros Therapeutics Inc (RPRX): Are Hedge Funds Right About This Stock?
Repros Therapeutics Inc (NASDAQ:RPRX) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
